Fact sheet: Wellington GlHthcrEq

Fund information
Fund name
Wellington Global Health Care Equity D Unhedged Acc USD
Fund manager company
Wellington Management Funds
Fund type
No data available.
Fund managers
  • Ann C Gallosince 24/06/1997
  • Jean M Hynessince 24/06/1997
Fund objective
The Wellington Global Health Care Equity Fund seeks long-term total returns. The Investment Manager will actively manage the Fund, seeking to achieve the objective by investing in the equity securities of health care companies worldwide. The Fund takes a long term value approach and seeks to invest in fundamentally sound companies. Although the Fund is not constructed relative to a benchmark, the MSCI World Health Care index will serve as a reference benchmark.
Benchmark
  • MSCI World Healthcare
Investment style
None
Investment method
Shares
Quick stats
1 Year return
6.8%
1 Year rank in sector
6/31
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
1.96%
Fund size
£1,394m (£1,474m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
146
Top in this sector
Fund name1 Year
BB Medtech20%
Pictet Health18.7%
Polar Capital Biotechnology18.6%
Variopartner SICAV MVGbMdtcF18.2%
Fidelity Gbl Health Care17.5%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • North America81.7%
    Europe9.7%
    Japan5.7%
    Global Emerging Markets2.6%
    Middle East0.3%
  • Biotechnology/Medical76.3%
    Health Care23.7%
  • North American Equities81.7%
    European Equities9.7%
    Japanese Equities5.7%
    Global Emerging Market Equities2.6%
    Middle East & African Equities0.3%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund4.9%4.2%0.5%6.8%30.5%132.7%
Sector3.1%1.6%0%4.4%21.8%103.9%
Rank within sector8 / 319 / 3113 / 316 / 3110 / 268 / 24
Quartile2nd2nd2nd1st2nd2nd
Calendar performance
 YTD - 20172016201520142013
Fund5.5%-10%14.6%27.7%48.3%
Sector4.3%-9.9%7.2%28.1%41%
Rank within sector11 / 3116 / 317 / 2917 / 269 / 24
Quartile2nd3rd1st3rd2nd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
2.3
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
1
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.35
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
17.34
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
5.97
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.35
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.88
Price movement
52 week high28.76
52 week low23.28
Current bid price-
Current offer price-
Current mid price27.83
Region
1North America81.7%
2Europe9.7%
3Japan5.7%
4Global Emerging Markets2.6%
5Middle East0.3%
Industry sector
1Biotechnology/Medical76.3%
2Health Care23.7%
Asset type
1North American Equities81.7%
2European Equities9.7%
3Japanese Equities5.7%
4Global Emerging Market Equities2.6%
5Middle East & African Equities0.3%
Individual holdings
1BRISTOL-MYERS SQUIBB CO4.2%
2UNITEDHEALTH GROUP INC4.1%
3ALLERGAN PLC3.7%
4ALKERMES PLC3.3%
5ASTRAZENECA PLC2.8%
6MERCK & CO INC(NEW)2.6%
7INCYTE CORP2.5%
8BOSTON SCIENTIFIC CORP2.4%
9MEDTRONIC PLC2.3%
Management
Fund manager group
Wellington Mgmt Portfolios
Fund manager company
Wellington Management Funds
Fund type
No data available.
Fund objective
The Wellington Global Health Care Equity Fund seeks long-term total returns. The Investment Manager will actively manage the Fund, seeking to achieve the objective by investing in the equity securities of health care companies worldwide. The Fund takes a long term value approach and seeks to invest in fundamentally sound companies. Although the Fund is not constructed relative to a benchmark, the MSCI World Health Care index will serve as a reference benchmark.
Benchmark
  • MSCI World Healthcare
Investment style
None
Investment method
Shares
Fund managers
NameSinceBiography
Ann C Gallo24/06/1997Ms. Ann C. Gallo is a Senior Managing Director, Senior Vice President, Partner, and Global Industry Analyst at Wellington Management Company LLP, and has been its Portfolio Manager since 1998. As a Global Industry Analyst in global industry research, Ms. Gallo specializes in the health care services industry. She conducts fundamental analysis on the companies within her industry and makes buy/sell recommendations to portfolio managers based on her findings and market conditions. Ms. Gallo is also a member of the firm’s health care team and is responsible for managing health and biotechnology sector mutual funds and hedge funds. She also serves as coordinator for several of the team-managed portfolios. Ms. Gallo joined the firm in 1998. She serves as a Portfolio Manager at Wellington Hedge Management LLC. Previously, Ms. Gallo was a Health Care Analyst with BT Alex. Brown from 1995 to 1998. She worked as an Investment Banker and Health Care Analyst at Piper Jaffray from 1992 to 1995. Previously, Ms. Gallo was a Financial Analyst with Citibank N.A. from 1991 to 1992 and an Accountant with Coopers & Lybrand from 1987 to 1989. She has extensive professional experience. Ms. Gallo earned an M.S. in Finance and Applied Economics from the Sloan School of Management, MIT, in 1991. She also received a B.S. from Boston College in 1987.
Jean M Hynes24/06/1997Ms. Jean Mariei Hynes, CFA is a Senior Managing Director, Senior Vice President, Partner, and Global Industry Analyst at Wellington Management Company LLP. Ms. Hynes joined the firm in 1991. As a Global Industry Analyst, she specializes in the pharmaceutical and biotechnology industries. Ms. Hynes conducts fundamental analysis on the companies within her industries and makes buy/sell recommendations to portfolio managers based on her findings and market conditions. She is a member of the health care team. She has extensive professional experience. Ms. Hynes is a member of the CFA Institute and the Boston Security Analysts Society. She holds the Chartered Financial Analyst designation. Ms. Hynes holds a B.A. in Economics from Wellesley College in 1991.
Compliance
Transparent for Austrian Tax, Transparent for German Tax, Reporting Fund Status, UCITS V Compliant
Domicile
No data available.
Fund for sale in
Austria, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Ireland, Italy, Luxembourg, Netherlands, Norway, Offshore, Singapore, Sweden
Wellington Global Health Care Equity D Unhedged Acc CHF
Initial charge-
Annual charge1.25%
Min single investment£5,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.96%
Total expense ratio (TER)1.97%
Bid price-
Offer price-
Mid price10.54
CurrencyCHF
Price updated13/01/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeM2BG
Wellington Global Health Care Equity D Unhedged Acc EUR
Initial charge-
Annual charge1.25%
Min single investment£5,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.96%
Total expense ratio (TER)1.97%
Bid price-
Offer price-
Mid price11.79
CurrencyEUR
Price updated13/01/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeM2BH
Wellington Global Health Care Equity D Unhedged Acc USD
Initial charge-
Annual charge1.25%
Min single investment£5,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.96%
Total expense ratio (TER)1.97%
Bid price-
Offer price-
Mid price27.83
CurrencyUSD
Price updated13/01/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeCQU8
Wellington Global Health Care Equity G Unhedged Acc USD
Initial charge-
Annual charge0.75%
Min single investment£5,000,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)0.81%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price60.62
CurrencyUSD
Price updated13/01/2017
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeWA31
Wellington Global Health Care Equity N Unhedged Acc EUR
Initial charge-
Annual charge1.25%
Min single investment£5,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.35%
Total expense ratio (TER)1.32%
Bid price-
Offer price-
Mid price10.88
CurrencyEUR
Price updated13/01/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeN5CK
Wellington Global Health Care Equity N Unhedged Acc GBP
Initial charge-
Annual charge1.25%
Min single investment£5,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.31%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price12.44
CurrencyGBP
Price updated13/01/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeMGOF
Wellington Global Health Care Equity N Unhedged Acc USD
Initial charge-
Annual charge1.25%
Min single investment£5,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.31%
Total expense ratio (TER)1.32%
Bid price-
Offer price-
Mid price20.28
CurrencyUSD
Price updated13/01/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeI8SQ
Wellington Global Health Care Equity S Unhedged Acc USD
Initial charge-
Annual charge1.25%
Min single investment£5,000,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)1.31%
Total expense ratio (TER)1.32%
Bid price-
Offer price-
Mid price46.83
CurrencyUSD
Price updated13/01/2017
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeWS71
Wellington Global Health Care Equity T Unhedged Acc GBP
Initial charge-
Annual charge-
Min single investment£5,000,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)0.06%
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price54.14
CurrencyGBP
Price updated13/01/2017
TypeAccumulation
Institutional or retail classInstitutional
Domicile-
Citi codeCQU9
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.